BACKGROUND	Previous results of the EORTC intergroup trial 40983 showed that perioperative chemotherapy with FOLFOX4 ( folinic acid , fluorouracil , and oxaliplatin ) increases progression-free survival ( PFS ) compared with surgery alone for patients with initially resectable liver metastases from colorectal cancer .\